Search

Search Results

• Analysis of Plasma Circulating Cell-Free DNA in Acute Myeloid Leukemia Patients

  Elena Nikolaevna Voropaeva, M.V. Burundukova, I.A. Kuznetsova, P.S. Orlov, A.M. Nesterets, S.V. Minnikh, V.N. Maximov, T.I. Pospelova

  347-354

  01.10.2025

• Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  340-346

  01.10.2025

• The Prognostic Value of Minimal Residual Disease Assessed During the Remission Induction Stage in Acute Myeloid Leukemia Patients

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, Yu.O. Davydova, N.M. Kapranov, K.A. Nikiforova, Yu.A. Chabaeva, L.A. Kuzmina, I.A. Lukianova, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  233-241

  01.07.2025

• Functional Cure as a New Concept of Therapy for Multiple Myeloma

  Sergei Vyacheslavovich Semochkin

  105-120

  01.04.2025

• Current Strategy and Principles of Multiple Myeloma Treatment: A Literature Review

  Aleksander Sergeevich Luchinin, A.A. Semenova, S.V. Semochkin

  153-162

  01.04.2025

• Bone Marrow Lymphocyte Subpopulation in Chronic Lymphocytic Leukemia Patients with Different Responses to Chemotherapy

  Olesya Nikolaevna Selyutina, E.Yu. Zlatnik, N.K. Guskova, I.A. Novikova, I.B. Lysenko, A.B. Sagakyants, T.F. Pushkareva, L.Yu. Vladimirova

  376-383

  01.10.2024

• The Importance of Complementary Immunological Markers in the Diagnosis of Minimal Residual Disease in Multiple Myeloma

  E.E. Tolstykh, O.S. Chuvadar, A.A. Semenova, N.A. Kupryshina, O.P. Kolbatskaya, Yu.I. Klyuchagina, O.A. Kolomeitsev, G.S. Tumyan, Nikolai Nikolaevich Tupitsyn

  388-395

  01.10.2022

• Multiple Myeloma: Nuances of Minimal Residual Disease Diagnosis and Monitoring with the Use of Multicolor Flow Cytometry

  I.V. Galtseva, Kseniya Aleksandrovna Nikiforova, Yu.O. Davydova, N.M. Kapranov, M.V. Solov’ev, E.N. Parovichnikova, L.P. Mendeleeva

  365-376

  01.10.2022

• Efficacy Predictors of the Third-Line Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Phase of Chronic Myeloid Leukemia: Results of a Multi-Center Study

  E.G. Lomaia, V.A. Shuvaev, Tamara Vangelevna Chitanava, Yu.D. Matvienko, I.S. Martynkevich, S.V. Voloshin, E.V. Efremova, E.S. Mileeva, M.S. Fominykh, A.E. Kersilova, E.V. Karyagina, N.V. Il’ina, N.V. Dorofeeva, N.V. Medvedeva, A.V. Klimovich, T.V. Shneider, S.A. Stepanova, N.F. Polezhaikovskaya, N.T. Siordiya, E.I. Sbityakova, N.S. Lazorko, E.N. Tochenaya, D.V. Motorin, N.A. Shnalieva, Yu.A. Alekseeva, D.B. Zammoeva, A.Yu. Zaritskey

  271-281

  01.07.2022

• ROR-1 Expression in the Diagnosis and Monitoring of Minimal Residual Disease in Chronic Lymphocytic Leukemia

  Evgenii Vladimirovich Pochtar, S.A. Lugovskaya, E.V. Naumova, E.A. Dmitrieva, V.V. Dolgov

  148-155

  01.04.2022

• Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

  Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva

  119-129

  01.04.2022

• Russian Prospective Non-Randomized Clinical Study on Dose Reduction of Tyrosine Kinase Inhibitors with Subsequent Complete Therapy Discontinuation in Chronic Myeloid Leukemia Patients with Stable Deep Molecular Response (READIT-2020): Background, Aim, Mai

  A.G. Turkina, Margarita Anatolevna Gurianova, E.Yu. Chelysheva, O.A. Shukhov

  54-61

  01.01.2022

• Technical Aspects of Minimal Residual Disease Detection by Multicolor Flow Cytometry in Acute Myeloid Leukemia Patients

  I.V. Galtseva, Yuliya Olegovna Davydova, N.M. Kapranov, K.A. Nikiforova, E.N. Parovichnikova

  503-512

  01.10.2021

• Molecular Profiling and Minimal Residual Disease Monitoring in Multiple Myeloma Patients: A Literature Review

  Aleksandra Vladimirovna Semyanikhina, E.E. Tolstykh

  436-443

  01.10.2021

• Biological Mechanisms of Sustaining Deep Molecular Response in Chronic Myeloid Leukemia Upon Withdrawal of Tyrosine Kinase Inhibitors

  Ekaterina Yurevna Chelysheva, M.A. Guryanova, A.G. Turkina

  427-435

  01.10.2021

• Multiple Myeloma and Dendritic Cell Vaccines

  Irina Vladimirovna Gribkova, A.A. Zavyalov

  370-377

  01.07.2021

• Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

  Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev

  145-153

  01.04.2019

• Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring

  Ol’ga Alekseevna Chernysheva, L.Yu. Grivtsova, I.N. Serebryakova, N.A. Kupryshina, E.N. Sholokhova, M.A. Shervashidze, A.D. Palladina, B.V. Kurdyukov, A.V. Popa, N.N. Tupitsyn

  79-85

  01.01.2019

• Magnetic Resonance Imaging of Bone Marrow and its Results as a Criterion for Administration of Maintenance Therapy After Auto-HSCT in Multiple Myeloma Patients

  Maksim Valer’evich Solov’ev, L.P. Mendeleeva, G.A. Yatsyk, N.S. Lutsik, M.V. Firsova, E.G. Gemdzhian, V.G. Savchenko

  360-367

  01.10.2018

• Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia

  Yuliya Vladimirovna Mirolyubova, E.A. Stadnik, V.V. Strugov, T.O. Andreeva, T.S. Nikulina, Yu.V. Virts, P.A. Butylin, A.G. Rumyantsev, A.Yu. Zaritskey

  167-174

  01.04.2018

• Ibrutinib in the Treatment of Relapsed Chronic Lymphocytic Leukemia

  Elena Aleksandrovna Stadnik, N.S. Timofeeva, V.V. Strugov, A.Yu. Zaritskey

  42-49

  01.01.2018

• Prognostic Value and Correlation Between WT1 Overexpression and NPM1 Mutation in Patients with Acute Myeloblastic Leukemia

  L.L. Girshova, Irina Garmaevna Budaeva, E.G. Ovsyannikova, S.O. Kuzin, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskii

  485-493

  01.10.2017

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• Evaluation of Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Using EuroFlow Approaches

  Ol’ga Alekseevna Beznos, L.Yu. Grivtsova, A.V. Popa, M.A. Shervashidze, I.N. Serebryakova, O.Yu. Baranova, E.A. Osmanov, N.N. Tupitsyn

  158-168

  01.04.2017

• WT1 Gene Overexpression in Oncohematological Disorders: Theoretical and Clinical Aspects (Literature Review)

  Nikolai Nikolaevich Mamaev, Ya.V. Gudozhnikova, A.V. Gorbunova

  257-264

  01.07.2016

• Chronic Lymphocytic Leukemia: Prognostic Significance of Minimal Residual Disease and Potential of Modern Methods of Its Diagnosis and Therapy (Literature Review)

  A.Yu. Kuvshinov, Sergei Vladimirovich Voloshi, I.S. Martynkevich, E.V. Kleina, M.A. Mikhaleva, K.M. Abdulkadyrov

  191-198

  01.04.2016

• Modern Aspects of Diagnosis and Treatment of Anaplastic Large Cell Lymphoma in Children (Literature Review)

  Andrei Sergeevich Levashov, T.T. Valiev, A.M. Kovrigina, A.V. Popa, G.L. Mentkevich

  199-207

  01.04.2016

• Relation between Genomic DNA Breakpoints in MLL Gene and Treatment Outcome in Infants with Acute Leukemia

  Grigorii Anatol’evich Tsaur, C. Meyer, T.O. Riger, A.M. Kustanovich, E.V. Fleischman, Yu.V. Ol’shanskaya, A.M. Popov, O.I. Sokova, E.A. Matveeva, O.V. Nikulina, A.E. Drui, O.R. Arakaev, O.V. Streneva, S.A. Rumyantsev, E.V. Shorikov, A.G. Solodovnikov, L.I. Savel’ev, R. Marschalek, L.G. Fechina

  22-29

  01.01.2016

• Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes and Clinical Significance of WT1 Gene Overexpression

  N.N. Mamaev, A.V. Gorbunova, T.L. Gindina, E.V. Morozova, Ya.V. Gudozhnikova, O.A. Slesarchuk, V.N. Ovechkina, A.A. Rats, E.G. Boichenko, E.A. Ukrainchenko, V.M. Kravtsova, A.V. Evdokimov, I.M. Barkhatov, S.N. Bondarenko, B.V. Afanas’ev

  551-563

  01.10.2014

• Chimerism following allogeneic hematopoietic stem cell transplantation

  O.V. Blau

  34-39

  01.01.2013

• New markers (CD160, CD200, and LAIR-1) in diagnosis of B-cell lymphoproliferative disorders

  S.A. Lugovskaya, D.G. Kisilichina, M.E. Pochtar, E.V. Naumova, E.A. Nikitin, L.S. Al-Rad

  46-52

  01.01.2013